AbbVie Stock Drops 09% on May 1 2025 with 1126 Billion Trading Volume Ranking 62nd in Market Activity
AbbVie Inc. (ABBV) shares fell 0.90% on May 1, 2025, with a trading volume of 11.26 billion, ranking 62nd in the day's market activity.
On December 6, 2023, Cerevel publicly announced that abbvie agreed to acquire Cerevel for $45 per share. The merger allowed Bain to receive a windfall of more.
Truist Financial raised their price target on shares of AbbVie from $211.00 to $217.00 and gave the company a “buy” rating in a research note on Monday.
Guggenheim Forecasts Strong Price Appreciation for AbbVie (NYSE:ABBV) Stock. AbbVie (NYSE:ABBV) Given New $216.00 Price Target at Guggenheim.
